-
ALMR share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of ALMR shares has decreased $0.34 since the market last closed. This is a 1.38% drop.
-
Last closed at $24.37.
The stock has since dropped $1.00 in pre-market trading.
Key terms
About ALMR
Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. Its products include ARGO HT system, NULISA assays for Immunology, neurology & oncology, NULISAqpcr custom assay development, technology access program and Alamar analysis solutions. The company was founded by Yuling Luo, Yiyuan Yin and Steve Chen in May 2018 and is headquartered in Fremont, CA.
-
Market cap: $1.69B
A market capitalization between $300 million and $2 billion places ALMR in the small capitalization category.
Key terms
Smart score
Latest ALMR news
ALMR Financials
-
ALMR total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
ALMR net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
ALMR earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
ALMR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ALMR Competitors
-
How competitors are chosen
ALMR's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.69B
A market capitalization between $300 million and $2 billion places ALMR in the small capitalization category.
